Abiopharma

Clinical trial NCT07347379 updates: 1. completion date: 2026-09-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-09-01 3. enrollment: 500 → 108 participants

Clinical trial NCT06565156 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-04-30 3. primary completion date: 2026-04-01 → 2025-11-14

Clinical trial NCT05776927 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-31 → 2026-08-04

Clinical trial NCT07549139 updates: 1. start date: 2026-06-30 → 2026-10-31 2. completion date: 2027-12-31 → 2028-04-30 3. primary completion date: 2027-12-31 → 2028-04-30

Clinical trial NCT05308901 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2027-06-01 → 2025-08-11

Clinical trial NCT06198712 updates: 1. collaborators added: Novo Nordisk A/S. This study is currently undergoing a sponsor transition from Forma Therapeutics, Inc. to Novo Nordisk A/S. 2. collaborators removed: Novo Nordisk A/S

Clinical trial NCT07636811 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-31 → 2026-08-31

Clinical trial NCT07575308 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-30 → 2026-07-30

Clinical trial NCT07194980: start date: 2026-08-01 → 2026-09-01.

Clinical trial NCT07549490: start date: 2026-08-16 → 2026-08-17.